Bioptamers
Bioptamers is dedicated to developing personalized precision therapies for cancer treatment. Their innovative approach utilizes aptamer technology to specifically identify and deliver therapeutic interventions to cancer cells, aiming to improve clinical outcomes and make science accessible through collaboration with universities, private companies, and hospitals.
Industries
Nr. of Employees
small (1-50)
Patents
Method for selecting aptamers with high target specificity in a microfluidic device platform for co-culture of multiple tissues
US-12565675-B2
View Details
Method for selecting aptamers with high target specificity in a microfluidic device platform for co-culture of multiple tissues
US-12565675-B2
View DetailsProducts
Personalized targeted therapeutic molecules (aptamer-derived)
Personalized synthetic molecules designed to specifically identify cancer cells and deliver therapeutic interventions; applicable to chemical, radiation-linked, and immunological therapies.
Personalized targeted therapeutic molecules (aptamer-derived)
Personalized synthetic molecules designed to specifically identify cancer cells and deliver therapeutic interventions; applicable to chemical, radiation-linked, and immunological therapies.
Services
End-to-end development and market preparation of personalized targeted therapeutic molecules, delivered through collaborative partnerships with academic and clinical institutions.
End-to-end development and market preparation of personalized targeted therapeutic molecules, delivered through collaborative partnerships with academic and clinical institutions.
Expertise Areas
- Aptamer therapeutics development
- Targeted drug delivery
- Personalized oncology therapeutics
- Manufacturing scale-up of synthetic therapeutics
Key Technologies
- Aptamer-based molecular targeting
- Targeted drug delivery systems
- Personalized therapeutic molecule design
- Synthetic therapeutic molecule production and industrialization